RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 47 filers reported holding RECRO PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,140 | -57.4% | 60,000 | 0.0% | 0.01% | -56.5% |
| Q2 2023 | $66,000 | -7.6% | 60,000 | 0.0% | 0.02% | -11.5% |
| Q1 2023 | $71,400 | -20.1% | 60,000 | 0.0% | 0.03% | -16.1% |
| Q4 2022 | $89,400 | -8.8% | 60,000 | 0.0% | 0.03% | -16.2% |
| Q3 2022 | $98,000 | +104.2% | 60,000 | 0.0% | 0.04% | +117.6% |
| Q2 2022 | $48,000 | -55.6% | 60,000 | 0.0% | 0.02% | -50.0% |
| Q1 2022 | $108,000 | +4.9% | 60,000 | 0.0% | 0.03% | 0.0% |
| Q4 2021 | $103,000 | +25.6% | 60,000 | +50.0% | 0.03% | +54.5% |
| Q3 2021 | $82,000 | -10.9% | 40,000 | 0.0% | 0.02% | +4.8% |
| Q2 2021 | $92,000 | +64.3% | 40,000 | +100.0% | 0.02% | +50.0% |
| Q1 2021 | $56,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
| Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
| MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
| Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
| Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
| Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
| Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
| Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
| AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |